Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death

<div>The results of MTT assay: cell viability of Jurkat cells after incubation in the presence of <b>5</b> (5–75 <i>µ</i>M) for 1 h (filled circles), 6 h (filled diamonds), 12 h (filled triangles), and 24 h (filled squares) at 37°C.</div>

Bioinorganic Chemistry and Applications

fig7

Figure 7

Figure 7: Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death 

Figure 7 | Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death 